SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,835,232 | -26.2% | 2,834,361 | -1.2% | 0.01% | -16.7% |
| Q2 2023 | $13,334,039 | +1.7% | 2,867,535 | +1.0% | 0.01% | -14.3% |
| Q1 2023 | $13,110,955 | -42.8% | 2,837,869 | -0.0% | 0.01% | -41.7% |
| Q4 2022 | $22,932,130 | +9.1% | 2,838,135 | -25.1% | 0.01% | +9.1% |
| Q3 2022 | $21,027,000 | +6.9% | 3,788,780 | +0.4% | 0.01% | +10.0% |
| Q2 2022 | $19,662,000 | -36.2% | 3,773,895 | +0.7% | 0.01% | -16.7% |
| Q1 2022 | $30,808,000 | -36.6% | 3,747,914 | +14.7% | 0.01% | -33.3% |
| Q4 2021 | $48,627,000 | -12.8% | 3,267,947 | +10.7% | 0.02% | -14.3% |
| Q3 2021 | $55,779,000 | +5.3% | 2,952,854 | +3.7% | 0.02% | +5.0% |
| Q2 2021 | $52,953,000 | -12.1% | 2,848,479 | +7.6% | 0.02% | -20.0% |
| Q1 2021 | $60,241,000 | +24.6% | 2,646,804 | +18.9% | 0.02% | +25.0% |
| Q4 2020 | $48,347,000 | – | 2,226,923 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |